Hepatic Carcinoma: Clinical Trials

3 trials for Hepatic Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Terminated 1, Unknown 1

Follow Hepatic Carcinoma: new trials by email Literature Review of Hepatic Carcinoma trials Research Report on Hepatic Carcinoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection
ETV;TDF;ADV, Peginterferon Alfa-2a - Chronic Hepatitis b, Hepatic Carcinoma
Phase 4UnknownHuashan Hospital4322017-09-012017-09-08
Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy
Huaier Granule - Hepatic Carcinoma
Phase 4TerminatedQidong Gaitianli Medicines Co., Ltd7902011-11-072020-03-06
Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy
Huaier Granule - Hepatic Carcinoma
Phase 4CompletedQidong Gaitianli Medicines Co., Ltd10442011-08-012017-10-02

Narrower conditions

Carcinoma, Hepatocellular (3)  ·  Hepatitis B, Chronic (1)  ·  Neoplasm Metastasis (1)

Broader conditions

Adenocarcinoma (3)  ·  Carcinoma (3)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Liver Diseases (3)  ·  Liver Neoplasms (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Blood-Borne Infections (1)  ·  Chronic Disease (1)  ·  Communicable Diseases (1)

Interventions

huaier (1)  ·  peginterferon alfa-2a (1)

Sponsors

Qidong Gaitianli Medicines Co., Ltd (2)  ·  Huashan Hospital (1)

Countries

China (3)

Top investigators

Xiaoping Chen, Professor (2)  ·  Jimimg Zhang (1)  ·  Lunxiu Qin (1)

Results publications

PMID 29802174